Patent · US Active

Quinazoline compounds

US9168253B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

HUTCHISON MEDIPHARMA LIMITED · CN

Inventors

Weihan Zhang · Shanghai, CN
Wei-Guo Su · Shanghai, CN
Haibin Yang · Shanghai, CN
Yumin Cui · Shanghai, CN
Yongxin Ren · Shanghai, CN
Xiaoqiang Yan · Shanghai, CN

Key dates

Filing date	May 25, 2011
Grant date	Oct 27, 2015
Priority date	—
Expiry date	Jan 30, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are certain quinazoline compounds, compositions thereof and methods of use thereof. These quinazoline compounds can effectively inhibit the overexpression and/or overactivity of epidermal growth factor receptor (EGFR).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.